metaXcMs is a software program for the analysis of liquid chromatography/mass spectrometry-based untargeted metabolomic data. It is designed to identify the differences between metabolic profiles across multiple sample groups (e.g., 'healthy' versus 'active disease' versus 'inactive disease'). although performing pairwise comparisons alone can provide physiologically relevant data, these experiments often result in hundreds of differences, and comparison with additional biologically meaningful sample groups can allow for substantial data reduction. By performing second-order (meta-) analysis, metaXcMs facilitates the prioritization of interesting metabolite features from large untargeted metabolomic data sets before the rate-limiting step of structural identification. Here we provide a detailed step-by-step protocol for going from raw mass spectrometry data to metaXcMs results, visualized as Venn diagrams and exported Microsoft excel spreadsheets. there is no upper limit to the number of sample groups or individual samples that can be compared with the software, and data from most commercial mass spectrometers are supported. the speed of the analysis depends on computational resources and data volume, but will generally be less than 1 d for most users. metaXcMs is freely available at http://metlin.scripps.edu/metaxcms/.
IntroDuctIon
Metabolites are the biochemical end products of gene activity, and they therefore provide a functional readout of cellular phenotype [1] [2] [3] . Untargeted metabolomics is the global and simultaneous profiling of as many metabolites as possible in a search to identify altered pathways that provide a phenotypic signature for the biological system of interest [4] [5] [6] [7] . The approach has been widely applied to elucidate biomarkers of disease, to discover new therapeutic targets, to assign unknown gene function and to gain mechanistic insight into physiological processes in plants, yeast, bacteria and mammals [8] [9] [10] [11] [12] [13] . Although historically much attention has been dedicated to the analysis of metabolites, until recently most studies focused on a relatively small number of compounds. However, developments in high-resolution mass spectrometers now enable the simultaneous detection of thousands of low-concentration species and have largely driven the field of global metabolic profiling over the course of the past 10 years 14, 15 . As with any 'omics' technology, the development of metabolomics has relied on advances in bioinformatic tools that are required for analysis of the complex data sets generated. The analytical technique that has proven to be the most suitable for looking at the largest number of compounds is liquid chromatography/mass spectrometry (LC/MS) 14, 16 . A typical LC/MS analysis of a metabolic extract from a biological tissue or fluid results in the detection of thousands of peaks, each characterized by a unique m/z value and/or retention time 17, 18 . The first bioinformatic challenge in LC/MS-based metabolomics was comparing the intensity of individual peaks, known as metabolite features, across all of the samples measured. A complication is that the retention time of a particular metabolite can change slightly from one run to the next due to experimental drift. Deviations in retention time (e.g., from fluctuations in the room temperature, time-dependent changes in the sample and column degradation) are nonlinear and complicate the feature assignments that are used for correlation between samples 19 . In 2005, a metabolomic program was developed called XCMS, which was used to identify dysregulated metabolite features between two sample groups by using a novel nonlinear retentiontime alignment algorithm that does not require the addition of internal standards 17 . XCMS is a freely available and platformindependent R package that processes, analyzes and visualizes LC/MS metabolomic data. XCMS is widely used in the field of untargeted metabolomics, with over 350 citations of the original paper and more than 45,000 downloads as of 2011.
Although XCMS and other metabolomic programs that have been developed are well suited for the analysis of large sample numbers, the programs are limited in that they only compare two different sample groups directly 20, 21 . Manual comparisons of multiple sets of XCMS results have been performed, but these studies involve only a small number of sample groups and require additional analysis time 22 . metaXCMS was developed to provide a tool for efficient metaanalysis of untargeted metabolomic data sets containing any number of sample groups 23 . Meta-analysis can be defined as an approach that compares the results from two or more independently performed studies to identify data points that are unique or shared among all or some of the experimental groups 24 . Figure 1 highlights the application of metaXCMS to identify unique and shared metabolite features that are dysregulated between three independent pairwise comparisons. Similar types of meta-analysis tools have been successfully applied in genome-wide association studies to investigate conditions with complex and heterogeneous phenotypes [25] [26] [27] .
Applications
To drive our understanding of chemical physiology, dysregulated metabolites and related cellular pathways need to be specifically correlated with unique biological processes or disease states. Often, however, an untargeted metabolomic analysis results in a substantial number of altered metabolite features and it is a major challenge to differentiate molecules that are causally associated with the phenotype of interest from those that are altered as a downstream effect.
Here metaXCMS provides a broadly applicable data-reduction strategy, as we recently showed in a study of three different mouse models of pain that were characterized by unique pathogenic etiology (Fig. 2) 
23
. Mice injected with complete Freund's adjuvant were used as an inflammatory model, those to which noxious heat was acutely applied to the hind paw were used as an acute heat model and mice that were intraperitoneally injected with serum from K/BxN mice were used as a pain model of spontaneous arthritis [28] [29] [30] . Although the pairwise comparisons of each pain model with its respective control resulted in hundreds of altered metabolite features in total, we suspected that at least some of these molecules may be involved in triggering the transduction of pain signals. The second-order analysis of the results with metaXCMS showed that only three of the altered molecules were shared among all of the models. We determined that one of the shared differences was the well-characterized pain mediator histamine, thereby validating the value of the metaanalysis for identifying mechanistically relevant metabolites causally associated with the phenotype of interest. A comparable approach could be applied to any type of disease or stress model.
As another example, we analyzed two knockout strains of Halobacterium salinarum. Specifically, knockout strains ∆VNG1816G and ∆VNG2094G were each compared with their parent control strain ∆ura3. The proteins encoded by VNG1816G and VNG2094G are known to affect glutamic acid metabolism 23, 31, 32 . As expected, results from metaXCMS showed a feature that was similarly dysregulated in the pairwise comparison of each mutant to its control; this was consistent with the accurate mass and retention time of glutamic acid (feature number 88, m/z 148.0606, retention time 5.8 min). The identity of glutamic acid was confirmed by comparing the retention time and MS/MS fragmentation pattern to that of a commercial standard. A truncated version of the XCMS files from each pairwise comparison is available for download as a test data set at http://metlin.scripps.edu/data/metaXCMS/metaXCMStestdata.zip. Expected results from performing the protocol described here are provided for comparison within the .zip file.
metaXCMS also has broad applicability in the more clinical context of biomarker elucidation. Traditionally, metabolite biomarker discovery has been performed by comparing healthy subjects to those affected by disease 33 . Most disease states of interest, however, are exceedingly complex and highly variable from subject to subject at different stages of progression and severity with potentially different prognoses 34 . In addition, there are a number of confounding variables that can be difficult to account for but that are known to influence metabolic profiles, such as sex, age, diet, drug regimen, ethnicity and body mass index 35 . Given the relatively good throughput of LC/MS-based metabolomics, it has become readily practical to analyze thousands of human patient samples 10, 11 . metaXCMS may be applied to compare subgroup populations within these large cohorts to identify metabolic predictors of disease course ( Fig. 3) and potential risk factors related to other clinical variables. In addition, metaXCMS analysis of phenotypically stratified subgroup populations similarly has utility in assessing drug efficacy. The comparison of subgroup difference profiles of patients on and off drug treatment (e.g., 'low blood pressure on drug' versus 'low blood pressure off drug' compared with 'high blood pressure on drug' versus 'high blood pressure off drug') will greatly facilitate the identification of variables affecting drug response and potential patients who are at risk of off-target effects.
Experimental design
Although untargeted metabolomics is generally hypothesis generating as opposed to hypothesis driven, it is important to carefully construct an experimental design to ensure that the results have value given the significant effort and time that are required for data analysis. Generally, the rate-limiting step in the untargeted metabolomic workflow is the structural identification of metabolites 36 . Although the untargeted profiling analysis provides the accurate mass of altered features between sample groups, these data must then be searched in metabolite libraries and structurally characterized by comparison of retention time and tandem MS data to that of standard model compounds. Thus, pairwise comparisons that yield hundreds of altered features can be challenging in that they require considerable effort and resources for identification. The incorporation of additional physiologically meaningful sample groups into the experimental design, however, can result in a reduced list of interesting features. Notably, this data reduction by meta-analysis is at the feature level before the rate-limiting step of structure determination. metaXCMS, therefore, has the potential to improve the overall throughput and efficiency of untargeted studies by prioritizing features to be identified that have a high likelihood of being biologically relevant. Two broadly applicable experimental designs using metaXCMS include the following: (i) the comparison of different variations of a disease or stress model to identify shared metabolic alterations related to a mechanistically fundamental response, and (ii) the comparison of phenotypically stratified patient cohorts to deconvolute metabolic responses associated with specific clinical variables and disease heterogeneity (results from the latter have yet to be published for metabolomic data, but similar designs have been used in genomics 27, 37, 38 ). Many other context-dependent applications are also conceivable, but in all cases certain experimental conditions should be followed for best results. First, the samples should be prepared using the same metabolite-extraction method. Different extraction methods may lead to the removal of different metabolites and thereby introduce artificial differences into the comparison 18 . In addition, because metaXCMS correlates peaks on the basis of m/z values and retention time, all samples being compared should be analyzed by using the same column and chromatographic method. These experimental requirements are limiting in that meta-comparisons of metabolomic analyses from different laboratories are likely to be unreliable. Although such inter-laboratory comparisons have intriguing potential, the protocol described here was not designed for that purpose. It should be noted, however, that meta-analyses from different laboratories should, in principle, provide the same profile of shared differences despite potential alterations in the retention times of specific compounds across different laboratories. Figure 4 shows an overview of the meta-analysis workflow. The process of file conversion, feature detection and alignment, and second-order analysis is described in the PROCEDURE. For details on data acquisition, see Want et al. 39 . For more details on result browsing and interpretation, see Smith et al. 17 and Tautenhahn et al. 23 . For a discussion regarding the appropriate number of samples per sample group, see Box 1. and c may serve as biomarkers, areas a and c could provide additional markers specific to mild and severe disease, respectively. The right Venn diagram shows a second-order visualization of the same comparison that is representative of metaXCMS output when the parameters are set to plot only metabolite features that are unique to disease (i.e., features that are detected in disease, but not in healthy samples). The advantage of the second-order visualization is that it is not limited to representing only metabolites unique to a certain sample group. Rather, metabolites that are up-and downregulated by even small fold changes can be easily represented according to user-defined thresholds. Given that biomarkers may not be metabolites unique to disease samples but instead metabolites that increase by some quantified fold change, second-order visualizations are generally better suited for metabolomic data as they can be used to show up-and downregulated features (see Venn diagram in Fig. 2) . Changing the second-order visualization here to include features with smaller fold changes, for example, would result in the display of more features that might represent useful diagnostic markers.
Box 1 | Number of samples per sample group
Currently, there is no consensus in the field with respect to the minimal number of samples that should be included per sample group for an untargeted metabolomic analysis. Similarly, different P value and fold change cutoffs are used depending on the biological system under investigation, the methods used for metabolite extraction and the analytical platform used. Studies have shown that instrument variability is smaller than biological variability for mammals and suggested that lower-limit fold change thresholds of 1.5-2.0 be used 35, 42 . These lower-limit fold change thresholds from individual pairwise comparisons are likely to be appropriate thresholds for meta-analysis. Although XCMS and metaXCMS can be used to analyze groups with as few as two samples, typically larger sample groups are needed because of intergroup biological variability. It should also be noted that it may be appropriate to apply a statistical correction for multiple comparisons (e.g., a Bonferroni correction) to metaXCMS results depending on the experimental design. These additional statistical tests are context-dependent and should be performed manually after metaXCMS analysis when appropriate.
MaterIals

EQUIPMENT
Hardware requirements
A personal computer with at least 2 GB RAM; a multicore processor with at least 2 GB RAM per core is recommended for the processing of large files/sample groups Sufficient hard-drive storage space for raw data files, converted files and results
Software requirements
For sample conversion: 32-or 64-bit versions of Windows operating system (XP, Vista, Windows 7)
• • • For XCMS and metaXCMS analysis: any 32-or 64-bit version of Windows, Unix operating system or Mac OS X (release 10.5 and above) can be used. However, as most 32-bit operating systems cannot allocate more than 2 GB RAM, 64-bit operating systems are recommended for working with large files/sample groups EQUIPMENT SETUP Software installation Install metaXCMS as described on http://metlin. scripps.edu/metaxcms/download.php. XCMS will be automatically installed during the installation of metaXCMS. In addition, download and install ProteoWizard (http://proteowizard.sourceforge.net/).  crItIcal Download the ProteoWizard version that includes vendor reader support.
• proceDure conversion of vendor-format data files to mzXMl 1| Locate MSConvertGUI.exe in the ProteoWizard folder and run it by double-clicking to call up the graphical user interface as shown in Figure 5 .
2| Click 'Browse' . Select the raw data files to convert. Multiple files can be selected at once.  crItIcal step ProteoWizard currently supports the conversion of Agilent, Applied Biosystems, Bruker, Thermo Fisher and Waters data files (see http://proteowizard. sourceforge.net/formats.shtml for information about other file formats).
3|
Click the filter selection dialog. Select 'Peak Picking' . Make sure 'Prefer Vendor' is activated.
4|
Click the 'Add' button to add peak picking to the filter list. This will make sure that the resulting files are in centroid mode, which is a requirement for the subsequent feature detection.
5|
Click 'Browse' to select the output directory. Select 'mzXML' as the output format.
6| Click 'Start' to begin file conversion.
pairwise comparison by using XcMs 7| Organize mzXML files in folders. Create a folder for each pairwise comparison. Inside this folder, create a subfolder for each group. Move all mzXML files that were acquired for the respective sample group into the corresponding folder. For example, make a folder 'variationA_vs_controlA' that contains subfolders for each group 'variation' and 'controlA', into which the individual mzXML files are copied.
8| Run R and load the XCMS package.
library(xcms)
9| Set the R working directory to the folder containing the files for the first pairwise comparison; for example, setwd('C:/Data/variationA_vs_controlA')  crItIcal step R uses the Unix-style forward slashes (/) as path separators on Windows operating systems; single backslashes (\) do not work.
10|
Start the feature detection using the 'centWave' method 40 .
xset < -xcmsSet(method = 'centWave') If you use a PC with multiple cores, add the argument nSlaves and specify the number of cores (e.g., for a PC with 2 cores, use the following code).
xset < -xcmsSet(method ='centWave', nSlaves = 2).
? trouBlesHootInG 11| Perform retention-time correction using the 'OBIwarp' method 41 .
xset1 < -retcor(xset, method = 'obiwarp', plottype = c('deviation'))
The retention-time correction curves should be displayed as represented in Figure 6 .
12| Group features together across samples. q('no') 15| Repeat Steps 8-14 for each of the pairwise comparisons.  crItIcal step Do not rename or move the data folders and do not rename the columns in the XCMS result table after XCMS processing. This will make metaXCMS unable to process the XCMS results.
Meta-analysis with metaXcMs 16| Run R and load the metaXCMS package (Fig. 7) .
library(metaXCMS)
? trouBlesHootInG 17| Click 'Import XCMS diffreport' . Navigate to the folder that contains the results from one of the pairwise comparisons and open the .tsv file (e.g., variationA_ vs_controlA.tsv). 
19|
Verify that sample classes have been assigned correctly by clicking on the file name of one of the pairwise comparisons on the left side of the window to select it. All sample names and the automatically assigned sample classes of that comparison are displayed on the right side of the window. If sample classes are assigned incorrectly, double-click and select the correct sample class from the pull-down menu.
20|
Verify that the control sample class is assigned correctly. The sample class that is used as a control for each pairwise comparison is shown in the column 'Control is' . If the assignment is incorrect, double-click and select the correct sample class from the pull-down menu. This will make sure metaXCMS can correctly display and filter up-and downregulated features.
21| Click 'Continue' to view filtering options (Fig. 8) .
22| Select fold change and P value thresholds for filtering. Note that P values are calculated in XCMS by performing a Welch's t test with unequal variance.
23| Click 'Apply filter' . The number of remaining features (green) will be updated.
24|
If only up-or downregulated features should be used from a pairwise comparison, click on 'all' and select 'UP' or 'DOWN' from the pull-down menu. Click 'Apply filter' . Figure 7 | Graphical user interface of metaXCMS. The input fields or icons related to the import of XCMS diffreports are indicated by arrows that are numbered according to the PROCEDURE step in which they are described. 28| Click 'Find common features' . After the alignment has been calculated, a Venn diagram with the numbers of unique and common features between the pairwise comparisons will be shown (Fig. 9) .
30|
To export a 33| Click 'Run Raw Data Alignment' . Retention-time correction for all samples will be recalculated (Fig. 10) .
? trouBlesHootInG 34| Click 'Generate EICs for common features' . After an output folder for the EICs has been selected, EICs will be generated for all common features by using the data from all samples. ? trouBlesHootInG ? trouBlesHootInG Troubleshooting advice can be found in table 2. If you see the error message: "Error: cannot allocate vector of size X Mb" (this might occur in any of Steps 10-13 and 17-34), it means that you have insufficient RAM. You will need to upgrade the RAM, and use a 64-bit operating system. If you experience problems not discussed here, please write a comment on this protocol and describe the problem in the XCMS/metaXCMS user forum at http://metlin.scripps.edu/xcms/faq.php. Retention-time correction for all samples compared is displayed and EICs are generated. The icons related to retention-time correction and EIC generation are indicated by arrows that are numbered according to the PROCEDURE steps in which they are described.
